Humabs BioMed, a subsidiary of Vir Biotechnology is a leading Swiss antibody therapeutics company that discovers and develops superior antibodies directly derived from individuals who have successfully overcome major diseases.
Location
Facts & figures
-
Type of organizationPrivate company
-
Year of foundation2004
-
Number of employees in Switzerland20-49